JP2021532176A5 - - Google Patents
Info
- Publication number
- JP2021532176A5 JP2021532176A5 JP2021524129A JP2021524129A JP2021532176A5 JP 2021532176 A5 JP2021532176 A5 JP 2021532176A5 JP 2021524129 A JP2021524129 A JP 2021524129A JP 2021524129 A JP2021524129 A JP 2021524129A JP 2021532176 A5 JP2021532176 A5 JP 2021532176A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- seq
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697939P | 2018-07-13 | 2018-07-13 | |
| US62/697,939 | 2018-07-13 | ||
| PCT/IB2019/000720 WO2020012244A2 (en) | 2018-07-13 | 2019-07-11 | Treating ulcerative colitis with brazikumab |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532176A JP2021532176A (ja) | 2021-11-25 |
| JP2021532176A5 true JP2021532176A5 (enExample) | 2022-08-15 |
Family
ID=68072845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524129A Pending JP2021532176A (ja) | 2018-07-13 | 2019-07-11 | ブラジクマブによる潰瘍性大腸炎の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210277105A1 (enExample) |
| EP (1) | EP3820897A2 (enExample) |
| JP (1) | JP2021532176A (enExample) |
| KR (1) | KR20210032441A (enExample) |
| CN (1) | CN112689643A (enExample) |
| AU (1) | AU2019300491A1 (enExample) |
| CA (1) | CA3105598A1 (enExample) |
| EA (1) | EA202190197A1 (enExample) |
| IL (1) | IL279917A (enExample) |
| SG (1) | SG11202100185VA (enExample) |
| WO (1) | WO2020012244A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| CN111718414B (zh) * | 2020-06-12 | 2021-03-02 | 江苏荃信生物医药有限公司 | 抗人白介素23单克隆抗体及其应用 |
| AU2023383916A1 (en) * | 2022-11-22 | 2025-07-10 | Janssen Biotech, Inc. | Method of treating ulcerative colitis with anti-il23 specific antibody |
| AU2025218720A1 (en) | 2024-02-06 | 2026-05-21 | Paragon Therapeutics, Inc. | Il-23 antibody compositions and methods of use |
| WO2025171006A1 (en) | 2024-02-06 | 2025-08-14 | Paragon Therapeutics, Inc. | Il-23 binding protein compositions and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| ZA986596B (en) | 1997-07-25 | 1999-02-08 | Schering Corp | Mammalian cytokine related reagents |
| CA2613818C (en) | 2005-06-30 | 2013-08-27 | Centocor, Inc. | Anti-il-23 antibodies, compositions, methods and uses |
| SI1937721T1 (sl) | 2005-08-25 | 2010-11-30 | Lilly Co Eli | Anti il protitelesa |
| ME02705B (me) | 2005-08-31 | 2017-10-20 | Merck Sharp & Dohme | Inženjerisana anti-il-23 antitela |
| SI3219328T1 (sl) | 2005-12-29 | 2020-10-30 | Janssen Biotech, Inc. | Človeška protitelesa proti-IL-23, sestavki, postopki in uporabe |
| JP2009540018A (ja) | 2006-06-13 | 2009-11-19 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法 |
| CN103396489A (zh) | 2007-02-23 | 2013-11-20 | 默沙东公司 | 工程改造的抗IL-23p19抗体 |
| HUE042172T2 (hu) | 2007-02-23 | 2019-06-28 | Merck Sharp & Dohme | Genetikailag elõállított anti-il-23P19 antitestek |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| WO2010027766A1 (en) | 2008-08-27 | 2010-03-11 | Schering Corporation | Lyophilized formulatons of engineered anti-il-23p19 antibodies |
| WO2010115786A1 (en) | 2009-04-01 | 2010-10-14 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| WO2010142534A1 (en) | 2009-05-27 | 2010-12-16 | Ablynx Nv | Biparatopic protein constructs directed against il-23 |
| JO3244B1 (ar) * | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| SI2523688T1 (en) | 2010-01-15 | 2018-03-30 | Kirin-Amgen, Inc. | Formulation of antibodies and therapeutic regimes |
| JP5972871B2 (ja) | 2010-07-20 | 2016-08-17 | テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド | 抗ｉｌ−２３ヘテロ二量体特異的抗体 |
| KR102049223B1 (ko) | 2010-11-04 | 2019-11-28 | 베링거 인겔하임 인터내셔날 게엠베하 | 항－ｉｌ－２３ 항체 |
| US20160031983A1 (en) * | 2013-03-15 | 2016-02-04 | Amgen Inc. | Methods for treating crohn's disease using an anti-il23 antibody |
-
2019
- 2019-07-11 JP JP2021524129A patent/JP2021532176A/ja active Pending
- 2019-07-11 AU AU2019300491A patent/AU2019300491A1/en not_active Abandoned
- 2019-07-11 EA EA202190197A patent/EA202190197A1/ru unknown
- 2019-07-11 SG SG11202100185VA patent/SG11202100185VA/en unknown
- 2019-07-11 KR KR1020217004216A patent/KR20210032441A/ko not_active Ceased
- 2019-07-11 US US17/259,448 patent/US20210277105A1/en not_active Abandoned
- 2019-07-11 CN CN201980046566.9A patent/CN112689643A/zh active Pending
- 2019-07-11 CA CA3105598A patent/CA3105598A1/en active Pending
- 2019-07-11 EP EP19779090.0A patent/EP3820897A2/en not_active Withdrawn
- 2019-07-11 WO PCT/IB2019/000720 patent/WO2020012244A2/en not_active Ceased
-
2021
- 2021-01-03 IL IL279917A patent/IL279917A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019523295A5 (enExample) | ||
| CN112689512B (zh) | 用于治疗银屑病的组合物和方法 | |
| JP2020500152A5 (enExample) | ||
| IL316408A (en) | A safe and effective method for treating psoriasis with a specific anti-IL23 antibody | |
| JP2024001125A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2024531151A5 (enExample) | ||
| JP2022188083A5 (enExample) | ||
| JP2021502349A5 (enExample) | ||
| JP2020502261A5 (enExample) | ||
| JP2023527542A5 (enExample) | ||
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| JP2021515770A5 (enExample) | ||
| JP2022536088A5 (enExample) | ||
| JP2017511316A (ja) | 爪および頭皮乾癬の治療方法 | |
| JP2024543885A5 (enExample) | ||
| JP2021530697A5 (enExample) | ||
| JP2022529929A5 (enExample) | ||
| JP2021523138A5 (enExample) | ||
| JP2024512255A5 (enExample) | ||
| JP2023524125A5 (enExample) | ||
| KR20180017145A (ko) | 소양증의 치료 | |
| JP2024542777A5 (enExample) | ||
| CN114588164B (zh) | 瑞马唑仑在预防围术期低体温和寒战中的应用 | |
| JP2022514561A5 (enExample) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi |